Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD

NCT04316559 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Opioid-Use Disorder

Interventions

OTHER: Placebo
DRUG: TRV734

Sponsor

National Institute on Drug Abuse (NIDA)